High-grade gliomas: Results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2429-2435

  Valeriani, Maurizio ^a,c   Ferretti, Antonio ^b   Franzese, Pietro ^b   Tombolini, Vincenzo ^b  

^a S Salvatore Hospital   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c NONE   (Italy)

Author keywords

Gliomas; Radio chemotherapy; Radiotherapy

Indexed keywords

TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 33745557768     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ries LAG, Eisner MP, Kosary CL et al (eds.): SEER Cancer Statistics, 1973-1998. Bethesda, MD, National Cancer Institute, 2001.
2. Greenlee RT, Hill- Harmon MB, Murray T and Thun M: Cancer Statistics, 2001. CA Cancer J Clin 51: 15-36, 2001.
3. Kleihues P, Burger PC and Scheithauer BW: The new WHO classification of brain tumor. Brain Pathol 3: 255-268, 1993.
4. Burger PC, Vogel FS, Green SB et al: Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
5. Walker MD, Alexander E Jr, Hunt WE et al: Evaluation of BCNU and / or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333-343, 1978.
6. Kristiansen K, Hagen S, Kollevold T et al: Combined modality therapy of operated astrocytomas grade III and IV: confirmation of the value of postoperative irradiation and lack of potentation of bleomycin on survival time - a prospective multicentre trial of the Scandinavian Glioblastoma Study Group. Cancer 52: 997-1007, 1983.
7. Azizi SA and Miyamoto C: Principles of treatment of malignant gliomas in adults: an overview. J Neurovirol 4: 204-216, 1998.
8. Levin V, Leibel S and Gudin P: Neoplasms of the central nervous system. In: De Vita V Jr, Hellman S, Rosemberg S (eds.). Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven, pp. 2022-2082, 1997.
9. Galanis E and Buckner J: Chemotherapy for high-grade gliomas. Br J Cancer 82: 1371-1380, 2000.
10. Andratschke N, Grosu AL, Molls M et al: Perspectives in the treatment of malignant gliomas in adults. Anticancer Res 21: 3541-3550, 2001.
11. Lesser GJ and Grossman SA: The chemotherapy of adult primary brain tumors. Cancer Treat Rev 19: 261-281, 1993.
12. Fine HA, Dear KB, Loaffler JS et al: Meta-analysis of radiation in adults. Cancer 71: 2585-2597, 1993.
13. O'Reilly SM, Newlands ES, Glaser MG, Brampton M, Rice-Edwards JM, Illingworth RD, Richards PG, Kennard C, Colquhoun IR, Lewis P and Stevens MFG: Temozolamide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer 29A: 940-942, 1993.
14. Newlands ES, Stevens MF, Wedge SR et al: Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23: 35-61, 1997.
15. Stupp R, Gander M, Leyvraz S et al: Current and future developments in the use of temozolomide for the treatment of brain tumors. Lancet Oncol 2: 552-560, 2001.
16. Friedman HS, Kerby T and Calvert H: Temozolomide and treatment of malignant glioma. Clin Cancer Res 6: 2585-2597, 2000.
17. Yung WK, Prados MD, Yaya-Tur R et al: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17: 2762-2771, 1999.
18. Yung WK, Albright RE, Olson J et al: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83: 588-593, 2000.
19. Reid JM, Stevens DC, Rubin J and Ames MM: Pharmacokinetics of 3-methyl-(triazen-1-yl) imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer. Clin Cancer Res 3: 2393-2398, 1997.
20. Newlands ES, Blackledge GR, Slack JA et al: Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 65: 287-291, 1992.
21. Patel M, McCully C, Godvin K and Balis F: Plasma and cerebrospinal fluid pharmacokinetics of temozolomide. Proc Am Soc Clin Oncol 14: 461, 1995 (abstract).
22. Marzolini C, Decosterd LA, Shen F et al: Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemother Pharmacol 42: 433-440, 1998.
23. Stupp R, Ostermann S, Leyvraz S et al: Cerebrospinal fluid levels of temozolomide as a surrogate marker for brain penetration. Proc Am Soc Clin Oncol 20: 59, 2001 (abstract).
24. Steel GG and Peckham MG: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5: 85-91, 1979.
25. Van Rijn J, Heimans JJ, van den Berg J et al: Survival of human glioma cells treated with various combinations of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 47: 779-784, 2000.
26. Wick W, Wick A, Schulz JB et al: Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 62: 1915-1919, 2002.
27. Kristiansen K, Hagen S, Kollevold T et al: Combined modality therapy of operated astrocytomas grade III and IV: confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time - a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47: 649-652, 1981.
28. Walker MD, Green SB, Byar DP et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980.
29. Andersen AP: Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol 17: 475-484, 1978.
30. Bleehen NM and Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64: 769-774, 1991.
31. Nelson DF, Diener-West M, Horton J et al: Combined modality approach to treatment of malignant gliomas - re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 6: 279-284, 1988.
32. Chan JL, Lee SW, Frass BA et al: Survival and failure patterns of high grade glioma after three-dimensional conformal radiotherapy. J Clin Oncol 20: 1635-1642, 2002.
33. Medical Research Council Brain Tumour Working Party: Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma. Med Res Council J Clin Oncol 19: 509-518, 2001.
34. Fine HA, Dear KBG, Loeffler JS et al: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993.
35. Barbara J, Fisher C, Scott DR, Macdonald C, Coughlin C and Curran WJ: Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of radiation therapy oncology group trial 9507. J Clin Oncol 19: 1111-1117, 2001.
36. Del Rowe J, Scott C, Werner-Wasik M, Bahary JP, Curran WJ, Urtasun RC and Fisher B: Single-arm open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol 18: 1254-1259, 2000.
37. Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M and Wharam M: The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys 44: 535-543, 1999.
38. Beauchesne P, Soler C, Boniol M et al: Response to a phase II study of concomitant-to-sequential use of etoposide and radiation therapy in newly diagnosed malignant gliomas. Am J Clin Oncol 26 (3): 22-27, 2003.
39. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002.
40. Stupp R, Dietrich PY, Kraljevic SO, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO and Leyvraz S: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375-1382, 2002.
41. Bauman GS, Gaspar LE, Fisher BJ et al: A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29: 835-839, 1994.
42. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH and Barnett GH: Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42: 981-987, 1998.
43. De Angelis LM: Radiotherapy of the brain in elderly patients. Eur J Cancer 36: 451-452, 2001.